{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:25:22Z","timestamp":1792787122010,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Opioid Reduction Consensus Panel Project"},{"name":"American Academy of Pain Medicine Foundation"},{"name":"Collegium Pharmaceutical","id":[{"id":"https:\/\/ror.org\/00q2vrq29","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Orexo US, Inc"},{"DOI":"10.13039\/100014235","name":"US WorldMeds, LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014235","name":"US WorldMeds, LLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mayocp.2020.04.025","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T08:11:24Z","timestamp":1601539884000},"page":"2155-2171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Ensuring Patient Protections When Tapering Opioids: Consensus Panel Recommendations"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3834-3001","authenticated-orcid":false,"given":"Edward C.","family":"Covington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Argoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane C.","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penney","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8368-1590","authenticated-orcid":false,"given":"Halena M.","family":"Gazelka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-6355","authenticated-orcid":false,"given":"W. Michael","family":"Hooten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan G.","family":"Kertesz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Manhapra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Steven P.","family":"Stanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mayocp.2020.04.025_bib1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/pm\/pny307","article-title":"Challenges with implementing the Centers for Disease Control and Prevention opioid guideline: a consensus panel report","volume":"20","author":"Kroenke","year":"2019","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.025_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/add.14394","article-title":"A\u00a0crisis of opioids and the limits of prescription control: United States","volume":"114","author":"Kertesz","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.mayocp.2020.04.025_bib3","first-page":"2261","article-title":"Characteristics of physicians who prescribe opioids for chronic pain: a meta-narrative systematic review","volume":"12","author":"Hooten","year":"2019","journal-title":"J\u00a0Pain Res"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.025_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2105\/AJPH.2014.302367","article-title":"A\u00a0comprehensive approach to address the prescription opioid epidemic in Washington State: milestones and lessons learned","volume":"105","author":"Franklin","year":"2015","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.mayocp.2020.04.025_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2105\/AJPH.2015.302953","article-title":"Opioid overdose deaths and Florida's crackdown on pill mills","volume":"106","author":"Kennedy-Hendricks","year":"2016","journal-title":"Am J Public Health"},{"issue":"10","key":"10.1016\/j.mayocp.2020.04.025_bib6","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1377\/hlthaff.2016.0448","article-title":"Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates","volume":"35","author":"Dowell","year":"2016","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.025_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7326\/M17-0598","article-title":"Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review","volume":"167","author":"Frank","year":"2017","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.mayocp.2020.04.025_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jamainternmed.2017.8709","article-title":"Patient-centered prescription opioid tapering in community outpatients with chronic pain","volume":"178","author":"Darnall","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.025_bib9","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/pm\/pny228","article-title":"International stakeholder community of pain experts and leaders call for an urgent action on forced opioid tapering","volume":"20","author":"Darnall","year":"2019","journal-title":"Pain Med"},{"key":"10.1016\/j.mayocp.2020.04.025_bib12","year":"2019"},{"key":"10.1016\/j.mayocp.2020.04.025_bib13","series-title":"FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering","year":"2019"},{"key":"10.1016\/j.mayocp.2020.04.025_bib14","series-title":"FDA Briefing Document: Joint Meeting of the Drug Safety and Risk Management (DSaRM) Advisory Committee and Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC)","year":"2019"},{"issue":"24","key":"10.1016\/j.mayocp.2020.04.025_bib15","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMp1904190","article-title":"No shortcuts to safer opioid prescribing","volume":"380","author":"Dowell","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocp.2020.04.025_bib16","doi-asserted-by":"crossref","first-page":"m283","DOI":"10.1136\/bmj.m283","article-title":"Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation","volume":"368","author":"Oliva","year":"2020","journal-title":"BMJ"},{"issue":"12","key":"10.1016\/j.mayocp.2020.04.025_bib17","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s11606-019-05301-2","article-title":"Mortality after discontinuation of primary care\u2013based chronic opioid therapy for pain: a retrospective cohort study","volume":"34","author":"James","year":"2019","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.mayocp.2020.04.025_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41394-018-0092-5","article-title":"The drive to taper opioids: mind the evidence, and the ethics","volume":"4","author":"Kertesz","year":"2018","journal-title":"Spinal Cord Ser Cases"},{"key":"10.1016\/j.mayocp.2020.04.025_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.genhosppsych.2017.04.011","article-title":"Suicidal ideation and suicidal self-directed violence following clinician-initiated prescription opioid discontinuation among long-term opioid users","volume":"47","author":"Demidenko","year":"2017","journal-title":"Gen Hosp Psychiatry"},{"issue":"15","key":"10.1016\/j.mayocp.2020.04.025_bib20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.mayocp.2020.04.025_bib24","series-title":"VA\/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain","year":"2017"},{"issue":"13","key":"10.1016\/j.mayocp.2020.04.025_bib25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","article-title":"Opioid abuse in chronic pain\u2014misconceptions and mitigation strategies","volume":"374","author":"Volkow","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mayocp.2020.04.025_bib26","doi-asserted-by":"crossref","first-page":"e192613","DOI":"10.1001\/jamanetworkopen.2019.2613","article-title":"Association between opioid dose variability and opioid overdose among adults prescribed long-term opioid therapy","volume":"2","author":"Glanz","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.025_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/j.pain.0000000000001128","article-title":"Dangerously numb: opioids, benzodiazepines, chronic pain, and posttraumatic stress disorder","volume":"159","author":"Sullivan","year":"2018","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.025_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/j.pain.0000000000001111","article-title":"Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans","volume":"159","author":"Gressler","year":"2018","journal-title":"Pain"},{"issue":"10","key":"10.1016\/j.mayocp.2020.04.025_bib29","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s11606-017-4288-3","article-title":"Prediction model for two-year risk of opioid overdose among patients prescribed chronic opioid therapy","volume":"33","author":"Glanz","year":"2018","journal-title":"J\u00a0Gen Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.025_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/ser0000099","article-title":"Development and applications of the Veterans Health Administration's Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide","volume":"14","author":"Oliva","year":"2017","journal-title":"Psychol Serv"},{"issue":"5","key":"10.1016\/j.mayocp.2020.04.025_bib31","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5664\/jcsm.26908","article-title":"Chronic opioid use is a risk factor for the development of central sleep apnea and ataxic breathing [published correction appears in J Clin Sleep Med. 2007;3(6):table of contents]","volume":"3","author":"Walker","year":"2007","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"9","key":"10.1016\/j.mayocp.2020.04.025_bib32","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1185\/03007990903120158","article-title":"Opioid switching and rotation in primary care: implementation and clinical utility","volume":"25","author":"Slatkin","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.mayocp.2020.04.025_bib33","first-page":"2587","article-title":"Practical management of opioid rotation and equianalgesia","volume":"11","author":"Treillet","year":"2018","journal-title":"J\u00a0Pain Res"},{"issue":"4","key":"10.1016\/j.mayocp.2020.04.025_bib34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1213\/00000539-200004000-00029","article-title":"Opioid substitution to improve the effectiveness of chronic noncancer pain control: a chart review","volume":"90","author":"Quang-Cantagrel","year":"2000","journal-title":"Anesth Analg"},{"issue":"11","key":"10.1016\/j.mayocp.2020.04.025_bib35","doi-asserted-by":"crossref","first-page":"e1916271","DOI":"10.1001\/jamanetworkopen.2019.16271","article-title":"Trends and rapidity of dose tapering among patients prescribed long-term opioid therapy, 2008-2017","volume":"2","author":"Fenton","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"39","key":"10.1016\/j.mayocp.2020.04.025_bib37","doi-asserted-by":"crossref","first-page":"E1222","DOI":"10.1503\/cmaj.170628","article-title":"Rethinking \"doing well\" on chronic opioid therapy","volume":"189","author":"Juurlink","year":"2017","journal-title":"CMAJ"},{"issue":"2","key":"10.1016\/j.mayocp.2020.04.025_bib38","first-page":"297","article-title":"Discrepancies between perceived benefit of opioids and self-reported patient outcomes","volume":"19","author":"Goesling","year":"2018","journal-title":"Pain Med"},{"key":"10.1016\/j.mayocp.2020.04.025_bib39","series-title":"Opioid use disorder diagnostic criteria. Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.025_bib40","first-page":"85","article-title":"Cohort study of the impact of high-dose opioid analgesics on overdose mortality [published correction appears in Pain Med. 2016;17(4):797-798]","volume":"17","author":"Dasgupta","year":"2016","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.mayocp.2020.04.025_bib41","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","article-title":"Opioid prescriptions for chronic pain and overdose: a cohort study","volume":"152","author":"Dunn","year":"2010","journal-title":"Ann Intern Med"},{"issue":"13","key":"10.1016\/j.mayocp.2020.04.025_bib42","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose\u2013related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.025_bib43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pain.2009.05.006","article-title":"Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders","volume":"145","author":"Weisner","year":"2009","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.mayocp.2020.04.025_bib44","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1001\/jamapsychiatry.2018.0544","article-title":"Physician prescribing of opioids to patients at increased risk of overdose from benzodiazepine use in the United States","volume":"75","author":"Ladapo","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.mayocp.2020.04.025_bib46","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2014.12.011","article-title":"Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes","volume":"52","author":"Bentzley","year":"2015","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"7","key":"10.1016\/j.mayocp.2020.04.025_bib47","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1097\/j.pain.0000000000000907","article-title":"Sustained improvements in pain, mood, function and opioid use post interdisciplinary pain rehabilitation in patients weaned from high and low dose chronic opioid therapy","volume":"158","author":"Huffman","year":"2017","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.mayocp.2020.04.025_bib48","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/pm\/pny231","article-title":"Does opioid tapering in chronic pain patients result in improved pain or same pain vs increased pain at taper completion? a structured evidence-based systematic review","volume":"20","author":"Fishbain","year":"2019","journal-title":"Pain Med"},{"issue":"6","key":"10.1016\/j.mayocp.2020.04.025_bib49","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.mayocp.2015.04.003","article-title":"Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice","volume":"90","author":"Berna","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.025_bib50","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11606-019-05227-9","article-title":"Opioid taper is associated with subsequent termination of care: a retrospective cohort study","volume":"35","author":"Perez","year":"2020","journal-title":"J\u00a0Gen Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.025_bib51","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/j.pain.0000000000000796","article-title":"Reasons for discontinuation of long-term opioid therapy in patients with and without substance use disorders","volume":"158","author":"Lovejoy","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.mayocp.2020.04.025_bib52","author":"Kurita"},{"issue":"12","key":"10.1016\/j.mayocp.2020.04.025_bib53","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1097\/j.pain.0000000000001680","article-title":"Refractory dependence on opioid analgesics","volume":"160","author":"Ballantyne","year":"2019","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.mayocp.2020.04.025_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/08990229009144706","article-title":"Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla","volume":"7","author":"Bederson","year":"1990","journal-title":"Somatosens Mot Res"},{"issue":"2","key":"10.1016\/j.mayocp.2020.04.025_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/AJP.0b013e3182579935","article-title":"Opioid cessation and multidimensional outcomes after interdisciplinary chronic pain treatment","volume":"29","author":"Murphy","year":"2013","journal-title":"Clin J Pain"},{"issue":"10","key":"10.1016\/j.mayocp.2020.04.025_bib56","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1097\/j.pain.0000000000001315","article-title":"Changes in pain intensity after discontinuation of long-term opioid therapy for chronic noncancer pain","volume":"159","author":"McPherson","year":"2018","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.025_bib57","first-page":"308","article-title":"Prescription opioid taper support for outpatients with chronic pain: a randomized controlled trial","volume":"18","author":"Sullivan","year":"2017","journal-title":"J\u00a0Pain"},{"issue":"2","key":"10.1016\/j.mayocp.2020.04.025_bib58","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/08897077.2017.1381663","article-title":"The conundrum of opioid tapering in long-term opioid therapy for chronic pain: a commentary","volume":"39","author":"Manhapra","year":"2018","journal-title":"Subst Abus"},{"issue":"suppl 1","key":"10.1016\/j.mayocp.2020.04.025_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2008.07.043","article-title":"Neurobiological substrates for the dark side of compulsivity in addiction","volume":"56","author":"Koob","year":"2009","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.mayocp.2020.04.025_bib60","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1526-4637.2010.00881.x","article-title":"Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain","volume":"11","author":"Shurman","year":"2010","journal-title":"Pain Med"},{"issue":"1507","key":"10.1016\/j.mayocp.2020.04.025_bib61","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1098\/rstb.2008.0094","article-title":"Neurobiological mechanisms for opponent motivational processes in addiction","volume":"363","author":"Koob","year":"2008","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.mayocp.2020.04.025_bib62","series-title":"Interagency Guideline on Prescribing Opioids for Pain","year":"2015"},{"key":"10.1016\/j.mayocp.2020.04.025_bib63","series-title":"HHS guide for clinicians on the appropriate dosage reduction or discontinuation of long-term opioid analgesics","year":"2019"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.025_bib64","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1682\/JRRD.2014.10.0250","article-title":"Sex differences between Veterans participating in interdisciplinary chronic pain rehabilitation","volume":"53","author":"Murphy","year":"2016","journal-title":"J\u00a0Rehabil Res Dev"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.025_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pain.2008.08.005","article-title":"A\u00a0longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission","volume":"140","author":"Townsend","year":"2008","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.mayocp.2020.04.025_bib66","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/PHM.0b013e31817c124f","article-title":"Withdrawal of analgesic medication for chronic low-back pain patients: improvement in outcomes of multidisciplinary rehabilitation regardless of surgical history","volume":"87","author":"Crisostomo","year":"2008","journal-title":"Am J Phys Med Rehabil"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.025_bib67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1526-4637.2007.00253.x","article-title":"Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia","volume":"8","author":"Hooten","year":"2007","journal-title":"Pain Med"},{"issue":"12","key":"10.1016\/j.mayocp.2020.04.025_bib68","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/pme.12201","article-title":"Opioid use 12 months following interdisciplinary pain rehabilitation with weaning","volume":"14","author":"Huffman","year":"2013","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.025_bib69","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02431544","article-title":"Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal","volume":"96","author":"Taylor","year":"1988","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.025_bib70","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0376-8716(99)00125-8","article-title":"Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment: a comparative inpatient study","volume":"59","author":"Pozzi","year":"2000","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.025_bib71","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/10826087109045540","article-title":"Doxepin: a useful adjunct in the treatment of heroin addicts in a methadone program","volume":"11","author":"Spensley","year":"1976","journal-title":"Int J Addict"},{"issue":"3","key":"10.1016\/j.mayocp.2020.04.025_bib72","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.pnpbp.2003.11.020","article-title":"Add-on gabapentin in the treatment of opiate withdrawal","volume":"28","author":"Mart\u00ednez-Raga","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.mayocp.2020.04.025_bib73","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/00952990802183921","article-title":"Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats","volume":"34","author":"Kang","year":"2008","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"9","key":"10.1016\/j.mayocp.2020.04.025_bib74","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1002\/jcph.1449","article-title":"Loperamide: a readily available but dangerous opioid substitute","volume":"59","author":"White","year":"2019","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.mayocp.2020.04.025_bib75","series-title":"Engineering, and Medicine. Medication-Assisted Treatment for Opioid Use Disorder: Proceedings of a Workshop\u2013in Brief","year":"2018"},{"issue":"6","key":"10.1016\/j.mayocp.2020.04.025_bib76","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.suponc.2012.05.002","article-title":"Twelve reasons for considering buprenorphine as a frontline analgesic in the management of pain","volume":"10","author":"Davis","year":"2012","journal-title":"J\u00a0Support Oncol"},{"issue":"5","key":"10.1016\/j.mayocp.2020.04.025_bib77","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1097\/ALN.0000000000000170","article-title":"Buprenorphine-naloxone therapy in pain management","volume":"120","author":"Chen","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/j.mayocp.2020.04.025_bib78","first-page":"859","article-title":"Buprenorphine \u2013 an attractive opioid with underutilized potential in treatment of chronic pain","volume":"8","author":"Khanna","year":"2015","journal-title":"J\u00a0Pain Res"},{"issue":"1","key":"10.1016\/j.mayocp.2020.04.025_bib79","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/10550887.2012.759872","article-title":"A\u00a0preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction","volume":"32","author":"Neumann","year":"2013","journal-title":"J\u00a0Addict Dis"},{"issue":"12","key":"10.1016\/j.mayocp.2020.04.025_bib80","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/pme.12520","article-title":"Conversion from high-dose full-opioid agonists to sublingual buprenorphine reduces pain scores and improves quality of life for chronic pain patients","volume":"15","author":"Daitch","year":"2014","journal-title":"Pain Med"},{"key":"10.1016\/j.mayocp.2020.04.025_bib82","doi-asserted-by":"crossref","first-page":"107537","DOI":"10.1016\/j.drugalcdep.2019.06.039","article-title":"Touchpoints \u2013 opportunities to predict and prevent opioid overdose: a cohort study","volume":"204","author":"Larochelle","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"3, Suppl Points & Pearls","key":"10.1016\/j.mayocp.2020.04.025_bib83","first-page":"S1","article-title":"Sedative-hypnotic drug withdrawal syndrome: recognition and treatment [digest]","volume":"19","author":"Santos","year":"2017","journal-title":"Emerg Med Pract"},{"issue":"5","key":"10.1016\/j.mayocp.2020.04.025_bib84","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/2045125317753340","article-title":"Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation","volume":"8","author":"Fluyau","year":"2018","journal-title":"Ther Adv Psychopharmacol"},{"issue":"9","key":"10.1016\/j.mayocp.2020.04.025_bib86","first-page":"CD005031","article-title":"Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification","author":"Amato","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.mayocp.2020.04.025_bib87","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jsat.2016.08.016","article-title":"Cognitive behavioral therapy improves treatment outcomes for prescription opioid users in primary care buprenorphine treatment","volume":"71","author":"Moore","year":"2016","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.mayocp.2020.04.025_bib89","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bbr.2014.05.061","article-title":"Effects of voluntary and treadmill exercise on spontaneous withdrawal signs, cognitive deficits and alterations in apoptosis-associated proteins in morphine-dependent rats","volume":"271","author":"Mokhtari-Zaer","year":"2014","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.mayocp.2020.04.025_bib90","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2018.05.044","article-title":"Treadmill exercise attenuates the severity of physical dependence, anxiety, depressive-like behavior and voluntary morphine consumption in morphine withdrawn rats receiving methadone maintenance treatment","volume":"681","author":"Alizadeh","year":"2018","journal-title":"Neurosci Lett"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620303955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620303955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:34:28Z","timestamp":1758418468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620303955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":80,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0025619620303955"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.04.025","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ensuring Patient Protections When Tapering Opioids: Consensus Panel Recommendations","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}